UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE (Anoro Ellipta) Nursing Considerations

What is the generic name?

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

What is the Trade Name for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

Anoro Ellipta

What are the Indications for UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

• 1 INDICATIONS AND USAGE ANORO ELLIPTA is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Important Limitations of Use ANORO ELLIPTA is NOT indicated for the relief of acute bronchospasm or for the treatment of asthma. The safety and efficacy of ANORO ELLIPTA in asthma have not been established. ANORO ELLIPTA is a combination of umeclidinium, an anticholinergic, and vilanterol, a long-acting beta 2 -adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). ( 1 ) Important limitations of use: Not indicated for relief of acute bronchospasm or for the treatment of asthma. ( 1 , 5.2 )

References: https://open.fda.gov/